e-learning
resources
London 2016
Tuesday, 06.09.2016
Mechanisms of disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Micro-RNA-125a/b target A20 and MAVS to promote inflammatory and impair antiviral responses in chronic obstructive pulmonary disease
Peter Wark (New Lambton, Australia), Peter Wark, Alan Hsu, Malcolm Starkey, Phil Hansbro
Source:
International Congress 2016 – Mechanisms of disease
Session:
Mechanisms of disease
Session type:
Poster Discussion
Number:
4658
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Peter Wark (New Lambton, Australia), Peter Wark, Alan Hsu, Malcolm Starkey, Phil Hansbro. Micro-RNA-125a/b target A20 and MAVS to promote inflammatory and impair antiviral responses in chronic obstructive pulmonary disease. Eur Respir J 2016; 48: Suppl. 60, 4658
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
The NLRP3 inflammasome in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Mechanisms of impaired anti-bacterial Th1 responses in patients with chronic obstructive pulmonary disease
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Source: Eur Respir J 2008; 31: 1334-1356
Year: 2008
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Source: Eur Respir J 2007; 30: 1043-1056
Year: 2007
Lymphoid follicles in (very) severe COPD: beneficial or harmful?
Source: Eur Respir J 2009; 34: 219-230
Year: 2009
The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Cell biology 2014
Year: 2014
COPD is associated with reduced pulmonary interstitial expression of pentraxin-3
Source: Eur Respir J 2012; 39: 830-838
Year: 2012
Evasion of COPD in smokers: at what price?
Source: Eur Respir J 2012; 39: 1298-1303
Year: 2012
The adaptive immune system, autoimmunity and COPD: lessons from human studies
Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD?
Year: 2007
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 78-85
Year: 2004
Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Pulmonary dendritic cells from chronic obstructive pulmonary disease patients suppress lung immune responses through induction of regulatory T cells
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
Multiple inflammatory hits and the pathogenesis of severe airway disease
Source: Eur Respir J 2006; 27: 884-888
Year: 2006
The novel compound Sul-121 inhibits inflammation in experimental models of chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 3-5
Year: 2004
Targeting the mTOR signaling pathway to inhibit lung cell senescence in chronic obstructive pulmonary disease (COPD)
Source: ERS Lung Science Conference 2017
Year: 2017
Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases
Source: Eur Respir J 2008; 32: 1068-1081
Year: 2008
IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept